{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:16:58Z","timestamp":1792725418135,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","award":["75F40122D00028\/75F40123F19002"],"award-info":[{"award-number":["75F40122D00028\/75F40123F19002"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.drugalcdep.2025.112776","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T19:40:47Z","timestamp":1751917247000},"page":"112776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Detected substances among patients with confirmed bromazolam exposure who present to the emergency department following a suspected opioid and\/or stimulant-related non-fatal overdose"],"prefix":"10.1016","volume":"274","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9488-3710","authenticated-orcid":false,"given":"Alyssa M.","family":"Falise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6444-142X","authenticated-orcid":false,"given":"Amanda","family":"Sutphin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5270-2608","authenticated-orcid":false,"given":"Rachel","family":"Culbreth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3198-2321","authenticated-orcid":false,"given":"Kim","family":"Aldy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8107-4818","authenticated-orcid":false,"given":"Keith","family":"Burkhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3763-4755","authenticated-orcid":false,"given":"Jeffrey","family":"Brent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharan L.","family":"Campleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aprielle","family":"Wills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-1882","authenticated-orcid":false,"given":"Alex","family":"Krotulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Wax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2025.112776_bib1","unstructured":"Abuse N.I. on D. Benzodiazepines and Opioids | National Institute on Drug Abuse (NIDA). November 7, 2022. Accessed August 13, 2024. \u3008https:\/\/nida.nih.gov\/research-topics\/opioids\/benzodiazepines-opioids\u3009"},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112776_bib2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jat\/bkae059","article-title":"A postmortem case report involving fentanyl, desalkylgidazepam, and bromazolam.","volume":"48","author":"Ballotari","year":"2024","journal-title":"J Anal Toxicol"},{"issue":"9","key":"10.1016\/j.drugalcdep.2025.112776_bib3","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1007\/s00204-024-03774-7","article-title":"In vitro structure-activity relationships and forensic case series of emerging 2-benzylbenzimidazole \u201cnitazene\u201d opioids","volume":"98","author":"De Vrieze","year":"2024","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.drugalcdep.2025.112776_bib4","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm725253a5","article-title":"Notes from the field: seizures, hyperthermia, and myocardial injury in three young adults who consumed bromazolam disguised as alprazolam \u2014 Chicago, Illinois, February 2023","volume":"72","author":"Ehlers","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.drugalcdep.2025.112776_bib5","article-title":"GABAA receptor subtypes and benzodiazepine use, misuse, and abuse","volume":"13","author":"Engin","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.drugalcdep.2025.112776_bib6","unstructured":"Geographic division or region - Health, United States. July 30, 2024. Accessed October 22, 2024. \u3008https:\/\/www.cdc.gov\/nchs\/hus\/sources-definitions\/geographic-region.htm\u3009"},{"key":"10.1016\/j.drugalcdep.2025.112776_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2023.111891","article-title":"Post mortem blood bromazolam concentrations and co-findings in 96 coronial cases within England and Wales","volume":"354","author":"Hikin","year":"2024","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2025.112776_bib8","article-title":"NPS Benzodiazepines in the United States","author":"Krotulski","year":"2025","journal-title":"Cent. Forensic Sci. Res. Educ."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112776_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jat\/bkad005","article-title":"Bromazolam blood concentrations in postmortem cases-a British Columbia perspective","volume":"47","author":"M\u00e9rette","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2025.112776_bib10","article-title":"Bromazolam prevalence surging across the united states driven in part by increasing detections alongside fentanyl","author":"Papsun","year":"2022","journal-title":"Cent. Forensic Sci. Res. Educ."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112776_bib11","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/10\/4\/045001","article-title":"Imputing defensible values for left-censored \u2018below level of quantitation\u2019 (LoQ) biomarker measurements","volume":"10","author":"Pleil","year":"2016","journal-title":"J. Breath. Res."},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112776_bib12","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/add.16520","article-title":"The surge of bromazolam-related fatalities replacing other novel designer benzodiazepines-related fatalities in San Francisco","volume":"119","author":"Rodda","year":"2024","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112776_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0033354919887741","article-title":"The emerging role of toxic adulterants in street drugs in the US illicit opioid crisis","volume":"135","author":"Singh","year":"2020","journal-title":"Public Health Rep."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112776_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.23907\/2017.039","article-title":"Levamisole: a high performance cutting agent","volume":"7","author":"Solomon","year":"2017","journal-title":"Acad. Forensic Pathol."},{"key":"10.1016\/j.drugalcdep.2025.112776_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625002297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625002297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T05:17:21Z","timestamp":1760591841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871625002297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":15,"alternative-id":["S0376871625002297"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112776","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detected substances among patients with confirmed bromazolam exposure who present to the emergency department following a suspected opioid and\/or stimulant-related non-fatal overdose","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112776"}}